Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab

被引:0
|
作者
Fayez Estephan
Xiaobu Ye
Omar Dzaye
Nina Wagner-Johnston
Lode Swinnen
Douglas E. Gladstone
Rich Ambinder
David Olayinka Kamson
Sebastian Lambrecht
Stuart A. Grossman
Doris D. M. Lin
Matthias Holdhoff
机构
[1] The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Department of Neurosurgery
[2] Johns Hopkins University School of Medicine,Russell H. Morgan Department of Radiology and Radiological Science
[3] Johns Hopkins University School of Medicine,Department of Radiology and Neuroradiology
[4] Charité,Division of Neuroradiology, Russell H. Morgan Department of Radiology and Radiological Science
[5] The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,undefined
[6] Johns Hopkins University School of Medicine,undefined
来源
Journal of Neuro-Oncology | 2019年 / 145卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The following discrepancies and errors were found in the original publication:
引用
收藏
页码:467 / 467
相关论文
共 50 条
  • [1] White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab
    Fayez Estephan
    Xiaobu Ye
    Omar Dzaye
    Nina Wagner-Johnston
    Lode Swinnen
    Douglas E. Gladstone
    Rich Ambinder
    David Olayinka Kamson
    Sebastian Lambrecht
    Stuart A. Grossman
    Doris D. M. Lin
    Matthias Holdhoff
    Journal of Neuro-Oncology, 2019, 145 : 461 - 466
  • [2] White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab
    Estephan, Fayez
    Ye, Xiaobu
    Grossman, Stuart A.
    Lin, Doris D.
    Holdhoff, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab (vol 145, pg 461, 2019)
    Estephan, Fayez
    Ye, Xiaobu
    Dzaye, Omar
    Wagner-Johnston, Nina
    Swinnen, Lode
    Gladstone, Douglas E.
    Ambinder, Rich
    Kamson, David Olayinka
    Lambrecht, Sebastian
    Grossman, Stuart A.
    Lin, Doris D. M.
    Holdhoff, Matthias
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (03) : 467 - 467
  • [4] Rituximab with high-dose methotrexate in primary central nervous system lymphoma
    Kansara, Roopesh
    Shenkier, Tamara N.
    Connors, Joseph M.
    Sehn, Laurie H.
    Savage, Kerry J.
    Gerrie, Alina S.
    Villa, Diego
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1149 - 1154
  • [5] Management of Patients With Primary Central Nervous System Lymphoma Treated With High-Dose Methotrexate
    Warnick, Elizabeth
    Auger, Danielle
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (02) : 177 - 180
  • [6] Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: Preliminary results in Vietnam
    Hoang, G. H. Nguyen
    Nguyen, P. T. B.
    Nguyen, H. T. N.
    Do, K. H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: A single-institution experience
    Ly, K. Ina
    Crew, Laura L.
    Graham, Carrie A.
    Mrugala, Maciej M.
    ONCOLOGY LETTERS, 2016, 11 (05) : 3471 - 3476
  • [8] Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients
    Guo, Yixian
    Lan, Xiaoxi
    Chang, Xiaoli
    Wang, Guoxiang
    Zou, Dongmei
    Su, Li
    Sun, Wanling
    BLOOD, 2021, 138
  • [9] High-dose methotrexate combined with rituximab improves the survival rate of patients with primary central nervous system lymphoma
    Ma, Jing
    Ma, Xianjun
    JOURNAL OF BUON, 2021, 26 (02): : 366 - 372
  • [10] Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma
    Mei, Shenghui
    Li, Xingang
    Jiang, Xueyun
    Yu, Kefu
    Lin, Song
    Zhao, Zhigang
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (05) : 1454 - 1460